AGCO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AGCO is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants a direct entry. The business fundamentals are improving, but the stock is sitting right around pivot resistance with mixed sentiment and insider selling. I would not call this a strong buy today; the better call is hold and wait for a cleaner setup or a pullback.
AGCO’s trend is moderately constructive but not strong enough to justify an aggressive buy at the current price. The stock closed at 117.54, just below the pivot at 117.744 and under first resistance at 121.431. Bullish moving averages are in place with SMA_5 > SMA_20 > SMA_200, which supports the longer-term trend. MACD histogram is positive at 0.164, but it is contracting, showing momentum is fading. RSI_6 at 48.8 is neutral, so there is no oversold buy signal. Overall, the technical picture is mixed: trend support exists, but near-term upside looks limited unless it breaks above resistance decisively.
It also beat non-GAAP EPS expectations at $0.94 and announced a higher quarterly dividend of $0.30 per share. The Rabobank financing partnership and sale of its 49% equity interest for $190M add balance-sheet support. Hedge funds have been buying aggressively, which is a positive institutional signal.
Insiders are selling sharply, which is the clearest negative flow signal. Analyst sentiment is mixed: several firms remain positive, but Oppenheimer cut its target from $136 to $134 and noted cautious demand, tariff-related cost pressure, and weaker visibility in LatAm. Baird flagged AGCO as a bearish Fresh Pick. The stock is also facing expected near-term weakness based on similar candlestick pattern analysis, with a negative next-day/week/month bias. Gross margin fell to 24.09%, down 2.23% YoY, showing profitability pressure despite top-line growth.
In Q1 2026, AGCO posted solid growth. Revenue increased 14.26% YoY to $2.34B, net income rose 423.81% YoY to $55M, and EPS climbed 442.86% YoY to $0.76. The latest quarter season is Q1 2026. The main weakness was gross margin, which dropped to 24.09%, down 2.23% YoY, indicating tariff and cost pressure even as operating performance improved. Overall, the latest quarter was clearly better than last year, but margin quality still needs work.
Analyst trend is broadly positive but slightly less enthusiastic than before. Oppenheimer remains Outperform but trimmed the target to $134 from $136, citing cautious demand and tariff costs. Earlier in April, Oppenheimer had raised the target to $136 from $132. Other firms are mixed: JPMorgan is Overweight at $138, Truist is Buy at $152, Wells Fargo is Equal Weight at $132, Citi is Neutral at $130, UBS is Neutral at $127, and Baird is Neutral with a bearish Fresh Pick call. Wall Street’s pro case is improving earnings, solid execution, and shareholder returns; the con case is tariff pressure, uneven demand visibility, and margin risk.
